{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:39:42Z","timestamp":1767796782317,"version":"3.49.0"},"reference-count":29,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,11,5]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>For ovarian cancer patients undergoing preoperative Neoadjuvant Chemotherapy (NACT), the toxicity of chemotherapeutic agents may cause hepatic and renal function impairment, altered sensitivity of the central nervous system or abnormal pain perception thresholds. These changes can further affect the metabolism and efficacy of intraoperative anaesthetics. However, the optimal intraoperative opioid dosage regimen for this specific patient population remains unclear. Currently, nociceptive stimulation monitoring technology has achieved certain progress in guiding intraoperative opioid administration. Among this technology, the index of consciousness 2 (IOC2), as a representative monitoring indicator in this field, provides important references for optimising opioid dosage regimens. This trial will investigate the opioid requirements and patient outcomes in the anaesthetic management of ovarian cancer patients undergoing preoperative NACT guided by IOC2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This prospective, single-blind, single-centre randomised controlled trial will randomly recruit 90 patients undergoing open ovarian cancer cytoreductive surgery under general anaesthesia, with equal numbers assigned to the control and experimental groups. The experimental group will adjust the remifentanil plasma target concentration based on the IOC2 value, while the control group will adjust according to the patients\u2019 mean arterial pressure. The primary outcome will be intraoperative opioid use (calculated in morphine equivalents per hour). Secondary outcomes include the average intraoperative propofol dose, post-anaesthesia care unit (PACU)-related metrics (including extubation time, time to spontaneous eye opening and morphine consumption in PACU), pain levels at 4, 24 and 48 hours postoperatively, as well as the use of analgesics and antiemetics. Postoperative recovery quality will also be assessed, including time to first flatus, time to ambulation, length of hospital stay and the 24-hour Quality of Recovery-15 (QoR-15) score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study involves human participants and was approved by the Ethics Committee of the Jiangsu Cancer Hospital (ethics no: XJS-2024-017). Patients gave informed consent to participate in the study before taking part. The study results will be published in peer-reviewed journals and presented at relevant academic conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ChiCTR2400091897.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-099607","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:21:15Z","timestamp":1764786075000},"page":"e099607","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of the index of consciousness 2 on intraoperative opioid dosage in ovarian cancer patients receiving neoadjuvant chemotherapy: a study protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8796-3615","authenticated-orcid":false,"given":"Yuyan","family":"Ding","sequence":"first","affiliation":[{"name":"Anesthesiology Department, Jiangsu Cancer Hospital\uff0cJiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paerhati","family":"Halisa","sequence":"additional","affiliation":[{"name":"Anesthesiology Department, Jiangsu Cancer Hospital\uff0cJiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingxi","family":"Xing","sequence":"additional","affiliation":[{"name":"Anesthesiology Department, Jiangsu Cancer Hospital\uff0cJiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0283-2359","authenticated-orcid":false,"given":"Lianbing","family":"Gu","sequence":"additional","affiliation":[{"name":"Anesthesiology Department, Jiangsu Cancer Hospital\uff0cJiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Anesthesiology Department, Jiangsu Cancer Hospital\uff0cJiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2026010703452972000_15.12.e099607.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.07.011"},{"key":"2026010703452972000_15.12.e099607.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21838"},{"key":"2026010703452972000_15.12.e099607.3","first-page":"100629","article-title":"Epithelial ovarian cancer: Review article","volume":"33","author":"Sambasivan","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"2026010703452972000_15.12.e099607.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.05.022"},{"key":"2026010703452972000_15.12.e099607.5","article-title":"Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer","volume":"7","author":"Coleridge","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026010703452972000_15.12.e099607.6","first-page":"211","article-title":"Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Single-Institution Experience and a Review of the Literature","volume":"91","author":"Loizzi","year":"2016","journal-title":"Oncology (Williston Park, NY)"},{"key":"2026010703452972000_15.12.e099607.7","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.7314\/APJCP.2015.16.6.2369","article-title":"Role of neoadjuvant chemotherapy in the management of advanced ovarian cancer","volume":"16","author":"Zhao","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"2026010703452972000_15.12.e099607.8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bja.2020.10.036","article-title":"Effects of noxious stimulation on the electroencephalogram during general anaesthesia: a narrative review and approach to analgesic titration","volume":"126","author":"Garc\u00eda","year":"2021","journal-title":"Br J Anaesth"},{"key":"2026010703452972000_15.12.e099607.9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.omtm.2020.05.032","article-title":"Effects of Depth of Anesthesia Monitored by IoC on Patients Undergoing Laparoscopic Radical Resection of Colorectal Cancer","volume":"18","author":"Zhao","year":"2020","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"key":"2026010703452972000_15.12.e099607.10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.8782","article-title":"Association of Opioid Consumption Profiles After Hospitalization With Risk of Adverse Health Care Events","volume":"4","author":"Kurteva","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026010703452972000_15.12.e099607.11","first-page":"100815","article-title":"Low-Dose Dexmedetomidine Reduces Median Effective Concentration (EC 50) of Propofol More than Fentanyl in Unparalysed Anaesthetised Patients for I-gel Insertion: a Randomised Controlled Trial","volume":"40","author":"Ganesh","year":"2021","journal-title":"Anaesth Crit Care Pain Med"},{"key":"2026010703452972000_15.12.e099607.12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10877-020-00540-9","article-title":"Comparison of haemodynamic- and electroencephalographic-monitored effects evoked by four combinations of effect-site concentrations of propofol and remifentanil, yielding a predicted tolerance to laryngoscopy of 90","volume":"35","author":"van den Berg","year":"2021","journal-title":"J Clin Monit Comput"},{"key":"2026010703452972000_15.12.e099607.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103763","article-title":"Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer-A prospective, randomized trial","volume":"76","author":"Brunner","year":"2024","journal-title":"Breast"},{"key":"2026010703452972000_15.12.e099607.14","first-page":"1482","article-title":"The effect of neoadjuvant chemotherapy on patient controlled intravenous analgesia postoperatively in ovarian cancer patients","volume":"90","author":"Fang","year":"2010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2026010703452972000_15.12.e099607.15","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14893","article-title":"Increased opioid consumption in neoadjuvant immunotherapy plus chemotherapy for patients with non-small-cell lung cancer: A multicenter, prospective cohort study","volume":"30","author":"Wang","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"2026010703452972000_15.12.e099607.16","doi-asserted-by":"crossref","first-page":"108230","DOI":"10.1016\/j.celrep.2020.108230","article-title":"The mTORC1\/S6K\/PDCD4\/eIF4A Axis Determines Outcome of Mitotic Arrest","volume":"33","author":"Moustafa-Kamal","year":"2020","journal-title":"Cell Rep"},{"key":"2026010703452972000_15.12.e099607.17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/acs.jmedchem.1c01690","article-title":"DNA-Unresponsive Platinum(II) Complex Induces ERS-Mediated Mitophagy in Cancer Cells","volume":"65","author":"Guo","year":"2022","journal-title":"J Med Chem"},{"key":"2026010703452972000_15.12.e099607.18","first-page":"170","article-title":"Expert consensus on standardized management of taxane-related peripheral neuropathy","volume":"42","author":"Fei","year":"2020","journal-title":"Chinese Journal of Oncology"},{"key":"2026010703452972000_15.12.e099607.19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/JS9.0000000000000360","article-title":"Intraoperative dexmedetomidine on postoperative pain in gastrointestinal surgery: an observational study","volume":"109","author":"Lv","year":"2023","journal-title":"Int J Surg"},{"key":"2026010703452972000_15.12.e099607.20","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001047"},{"key":"2026010703452972000_15.12.e099607.21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jamasurg.2023.2009","article-title":"Association of Intraoperative Opioid Administration With Postoperative Pain and Opioid Use","volume":"158","author":"Santa Cruz Mercado","year":"2023","journal-title":"JAMA Surg"},{"key":"2026010703452972000_15.12.e099607.22","first-page":"222","article-title":"Application of closed-loop target controlled infusion(TCI)of propofol combined with pain and nociception index-guided remifentanil tci in gynecological laparoscopic surgery","volume":"124","author":"Wang","year":"2020","journal-title":"Journal of Shanxi Medical"},{"key":"2026010703452972000_15.12.e099607.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12871-023-02022-2","article-title":"Real-time evaluation of the independent analgesic efficacy of dexmedetomidine","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"2026010703452972000_15.12.e099607.24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bja.2019.09.041","article-title":"Predicting acute postoperative pain by the Qnox score at the end of surgery: a prospective observational study","volume":"124","author":"Ledowski","year":"2020","journal-title":"Br J Anaesth"},{"key":"2026010703452972000_15.12.e099607.25","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-016-1298-0","article-title":"Effects of indexes of consciousness (IoC1 and IoC2) monitoring on remifentanil dosage in modified radical mastectomy: a randomized trial","volume":"17","author":"Wu","year":"2016","journal-title":"Trials"},{"key":"2026010703452972000_15.12.e099607.26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bja.2022.04.014","article-title":"Association between long-term opioid use and cancer risk in patients with chronic pain: a propensity score-matched cohort study","volume":"129","author":"Sun","year":"2022","journal-title":"Br J Anaesth"},{"key":"2026010703452972000_15.12.e099607.27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ejp.1506","article-title":"The effects of long-term opioid treatment on the immune system in chronic non-cancer pain patients: A systematic review","volume":"24","author":"Diasso","year":"2020","journal-title":"Eur J Pain"},{"key":"2026010703452972000_15.12.e099607.28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/ALN.0000000000004840","article-title":"Opioid-free Anesthesia Protocol on the Early Quality of Recovery after Major Surgery (SOFA Trial): A Randomized Clinical Trial","volume":"140","author":"L\u00e9ger","year":"2024","journal-title":"Anesthesiology"},{"key":"2026010703452972000_15.12.e099607.29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/ALN.0000000000002634","article-title":"Nociception-guided versus Standard Care during Remifentanil-Propofol Anesthesia: A Randomized Controlled Trial","volume":"130","author":"Meijer","year":"2019","journal-title":"Anesthesiology"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-099607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:45:43Z","timestamp":1767786343000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-099607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,3]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjopen-2025-099607"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-099607","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}